TrialCancer science2018

ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor-naïve Japanese patients with EGFR mutation-positive non-small-cell lung cancer.

Koichi Azuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.